Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections-Reference-Cited by-同舟云学术

Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections

Published:2017-05 Issue:5 Volume:27 Page:190-196
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Hamadeh Issam S.,Klinker Kenneth P.,Borgert Samuel J.,Richards Ashley I.,Li Wenhui,Mangal Naveen,Hiemenz John W.,Schmidt Stephan,Langaee Taimour Y.,Peloquin Charles A.,Johnson Julie A.,Cavallari Larisa H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference45 articles.

1. Aspergillosis case-fatality rate: systematic review of the literature;Lin;Clin Infect Dis,2001

2. Aspergillus infections in transplant recipients;Singh;Clin Microbiol Rev,2005

3. Voriconazole concentrations and outcome of invasive fungal infections;Miyakis;Clin Microbiol Infect,2010

4. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America;Walsh;Clin Infect Dis,2008

5. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis;Herbrecht;N Engl J Med,2002

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical pharmacology of antiinfective drugs;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Voriconazole therapeutic drug monitoring including analysis of CYP2C19 phenotype in immunocompromised pediatric patients with invasive fungal infections;European Journal of Clinical Pharmacology;2024-09-06

3. Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactions;Drug Metabolism Reviews;2024-08-18

4. WHICH TOOL IS THE BEST GUIDE OPTIMIZE THE VORICONAZOLE DOSAGE: THERAPEUTIC DRUG MONITORING OR CYTOCHROME P450 POLYMORPHISM?;Sağlık Bilimleri Dergisi;2024-07-25

5. Mass spectrometric methods for evaluation of voriconazole avian pharmacokinetics and the inhibition of its cytochrome P450-induced metabolism;Toxicology Mechanisms and Methods;2024-02-29